• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53以细胞命运依赖的方式在间充质分化程序中发挥作用。

p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner.

作者信息

Molchadsky Alina, Shats Igor, Goldfinger Naomi, Pevsner-Fischer Meirav, Olson Melissa, Rinon Ariel, Tzahor Eldad, Lozano Guillermina, Zipori Dov, Sarig Rachel, Rotter Varda

机构信息

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

出版信息

PLoS One. 2008;3(11):e3707. doi: 10.1371/journal.pone.0003707. Epub 2008 Nov 12.

DOI:10.1371/journal.pone.0003707
PMID:19002260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2577894/
Abstract

BACKGROUND

The tumor suppressor p53 is an important regulator that controls various cellular networks, including cell differentiation. Interestingly, some studies suggest that p53 facilitates cell differentiation, whereas others claim that it suppresses differentiation. Therefore, it is critical to evaluate whether this inconsistency represents an authentic differential p53 activity manifested in the various differentiation programs.

METHODOLOGY/PRINCIPAL FINDINGS: To clarify this important issue, we conducted a comparative study of several mesenchymal differentiation programs. The effects of p53 knockdown or enhanced activity were analyzed in mouse and human mesenchymal cells, representing various stages of several differentiation programs. We found that p53 down-regulated the expression of master differentiation-inducing transcription factors, thereby inhibiting osteogenic, adipogenic and smooth muscle differentiation of multiple mesenchymal cell types. In contrast, p53 is essential for skeletal muscle differentiation and osteogenic re-programming of skeletal muscle committed cells.

CONCLUSIONS

These comparative studies suggest that, depending on the specific cell type and the specific differentiation program, p53 may exert a positive or a negative effect, and thus can be referred as a "guardian of differentiation" at large.

摘要

背景

肿瘤抑制因子p53是一种重要的调节因子,可控制包括细胞分化在内的各种细胞网络。有趣的是,一些研究表明p53促进细胞分化,而另一些研究则称其抑制分化。因此,评估这种不一致是否代表在各种分化程序中表现出的真实差异p53活性至关重要。

方法/主要发现:为了阐明这一重要问题,我们对几种间充质分化程序进行了比较研究。在代表几种分化程序不同阶段的小鼠和人间充质细胞中分析了p53敲低或活性增强的影响。我们发现p53下调主要分化诱导转录因子的表达,从而抑制多种间充质细胞类型的成骨、成脂和平滑肌分化。相反,p53对于骨骼肌分化和骨骼肌定向细胞的成骨重编程至关重要。

结论

这些比较研究表明,根据特定的细胞类型和特定的分化程序,p53可能发挥正面或负面作用,因此总体上可被称为“分化守护者”。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/aebb5fa2531b/pone.0003707.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/2771583fa8c3/pone.0003707.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/1b5649f7c9db/pone.0003707.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/9168a5fd8c1c/pone.0003707.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/100244776691/pone.0003707.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/82a585c1a902/pone.0003707.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/f108a8e7a7a2/pone.0003707.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/51c489b18520/pone.0003707.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/aebb5fa2531b/pone.0003707.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/2771583fa8c3/pone.0003707.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/1b5649f7c9db/pone.0003707.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/9168a5fd8c1c/pone.0003707.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/100244776691/pone.0003707.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/82a585c1a902/pone.0003707.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/f108a8e7a7a2/pone.0003707.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/51c489b18520/pone.0003707.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc8/2577894/aebb5fa2531b/pone.0003707.g008.jpg

相似文献

1
p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner.p53以细胞命运依赖的方式在间充质分化程序中发挥作用。
PLoS One. 2008;3(11):e3707. doi: 10.1371/journal.pone.0003707. Epub 2008 Nov 12.
2
Wnt/ß-catenin-mediated p53 suppression is indispensable for osteogenesis of mesenchymal progenitor cells.Wnt/β-catenin 介导的 p53 抑制对于间充质祖细胞的成骨作用是必不可少的。
Cell Death Dis. 2021 May 21;12(6):521. doi: 10.1038/s41419-021-03758-w.
3
Basal p53 expression is indispensable for mesenchymal stem cell integrity.基底 p53 表达对于间充质干细胞的完整性是不可或缺的。
Cell Death Differ. 2018 Mar;25(4):679-692. doi: 10.1038/s41418-017-0004-4. Epub 2018 Jan 8.
4
Mouse bone marrow mesenchymal stem cells with distinct p53 statuses display differential characteristics.具有不同 p53 状态的小鼠骨髓间充质干细胞表现出不同的特征。
Mol Med Rep. 2020 May;21(5):2051-2062. doi: 10.3892/mmr.2020.11025. Epub 2020 Mar 12.
5
Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation.Maf 促进了小鼠成骨细胞的分化,通过介导间充质细胞分化的与年龄相关的转变。
J Clin Invest. 2010 Oct;120(10):3455-65. doi: 10.1172/JCI42528. Epub 2010 Sep 27.
6
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts.长期抑制 Mdm2-p53 相互作用可增强间充质干细胞向成骨细胞的分化。
Biochim Biophys Acta Mol Cell Res. 2019 May;1866(5):737-749. doi: 10.1016/j.bbamcr.2019.01.012. Epub 2019 Jan 28.
7
p53 loss increases the osteogenic differentiation of bone marrow stromal cells.p53缺失会增加骨髓基质细胞的成骨分化。
Stem Cells. 2015 Apr;33(4):1304-19. doi: 10.1002/stem.1925.
8
A Reciprocal Role of the Smad4-Taz Axis in Osteogenesis and Adipogenesis of Mesenchymal Stem Cells.Smad4-Taz 轴在间充质干细胞成骨和成脂中的相互作用。
Stem Cells. 2019 Mar;37(3):368-381. doi: 10.1002/stem.2949. Epub 2018 Dec 7.
9
The transcription factor NKX1-2 promotes adipogenesis and may contribute to a balance between adipocyte and osteoblast differentiation.转录因子 NKX1-2 促进脂肪生成,可能有助于维持脂肪细胞和成骨细胞分化之间的平衡。
J Biol Chem. 2019 Nov 29;294(48):18408-18420. doi: 10.1074/jbc.RA119.007967. Epub 2019 Oct 15.
10
Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat.氧化甾醇调节间充质干细胞的分化:促进成骨和抑制成脂。
J Bone Miner Res. 2004 May;19(5):830-40. doi: 10.1359/JBMR.040115. Epub 2004 Jan 12.

引用本文的文献

1
Pooled CRISPR screens identifies key regulators of bovine stem cell expansion for cultured meat.汇集式CRISPR筛选确定了用于培养肉的牛干细胞扩增的关键调节因子。
Commun Biol. 2025 Aug 30;8(1):1313. doi: 10.1038/s42003-025-08760-y.
2
White Adipocyte Stem Cell Expansion Through Infant Formula Feeding: New Insights into Epigenetic Programming Explaining the Early Protein Hypothesis of Obesity.通过婴儿配方奶粉喂养实现白色脂肪干细胞扩增:肥胖早期蛋白质假说的表观遗传编程新见解
Int J Mol Sci. 2025 May 8;26(10):4493. doi: 10.3390/ijms26104493.
3
Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion.

本文引用的文献

1
p53 regulates maternal reproduction through LIF.p53通过白血病抑制因子调控母体生殖。
Nature. 2007 Nov 29;450(7170):721-4. doi: 10.1038/nature05993.
2
Nanog inhibits the switch of myogenic cells towards the osteogenic lineage.Nanog抑制成肌细胞向成骨谱系的转变。
Biochem Biophys Res Commun. 2008 Jan 25;365(4):846-50. doi: 10.1016/j.bbrc.2007.11.073. Epub 2007 Nov 26.
3
Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancer.有尾目动物的p53能耐受与人类癌症相关的p53变体中发现的氨基酸变化。
神经损伤诱导蛋白2,一种细胞粘附分子及p53的靶点,在生长抑制中调节野生型p53并在生长促进中调节突变型p53。
Cancers (Basel). 2024 Jan 4;16(1):229. doi: 10.3390/cancers16010229.
4
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.LSD1 通过抑制 TP53 信号通路来促进前列腺癌重编程,而不依赖其去甲基化酶功能。
JCI Insight. 2023 Aug 8;8(15):e167440. doi: 10.1172/jci.insight.167440.
5
Role of p53 in promoting BMP9‑induced osteogenic differentiation of mesenchymal stem cells through TGF‑β1.p53通过转化生长因子β1(TGF-β1)在促进骨形态发生蛋白9(BMP9)诱导的间充质干细胞成骨分化中的作用
Exp Ther Med. 2023 Apr 13;25(6):248. doi: 10.3892/etm.2023.11947. eCollection 2023 Jun.
6
Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma.巨噬细胞再极化作为骨肉瘤的治疗策略。
Int J Mol Sci. 2023 Feb 2;24(3):2858. doi: 10.3390/ijms24032858.
7
Abnormal signal pathways and tumor heterogeneity in osteosarcoma.骨肉瘤中异常的信号通路和肿瘤异质性。
J Transl Med. 2023 Feb 9;21(1):99. doi: 10.1186/s12967-023-03961-7.
8
A Review of Signaling Transduction Mechanisms in Osteoclastogenesis Regulation by Autophagy, Inflammation, and Immunity.自噬、炎症与免疫调控破骨细胞分化的信号转导机制研究进展
Int J Mol Sci. 2022 Aug 30;23(17):9846. doi: 10.3390/ijms23179846.
9
Focal adhesion kinase inhibitors prevent osteoblast mineralization in part due to suppression of Akt-mediated stabilization of osterix.粘着斑激酶抑制剂部分地通过抑制Akt介导的osterix稳定性来阻止成骨细胞矿化。
J Bone Oncol. 2022 May 13;34:100432. doi: 10.1016/j.jbo.2022.100432. eCollection 2022 Jun.
10
Mesenchymal Stem Cell Senescence and Osteogenesis.间质干细胞衰老与成骨作用。
Medicina (Kaunas). 2021 Dec 31;58(1):61. doi: 10.3390/medicina58010061.
BMC Evol Biol. 2007 Sep 28;7:180. doi: 10.1186/1471-2148-7-180.
4
A spatially and temporally restricted mouse model of soft tissue sarcoma.一种软组织肉瘤的时空受限小鼠模型。
Nat Med. 2007 Aug;13(8):992-7. doi: 10.1038/nm1602. Epub 2007 Aug 5.
5
Myocardin in tumor suppression and myofibroblast differentiation.心肌素在肿瘤抑制及肌成纤维细胞分化中的作用
Cell Cycle. 2007 May 15;6(10):1141-6. doi: 10.4161/cc.6.10.4251. Epub 2007 May 9.
6
p53: new roles in metabolism.p53:在新陈代谢中的新作用。
Trends Cell Biol. 2007 Jun;17(6):286-91. doi: 10.1016/j.tcb.2007.04.004. Epub 2007 May 3.
7
The p53 family in differentiation and tumorigenesis.p53家族在分化与肿瘤发生过程中的作用
Nat Rev Cancer. 2007 Mar;7(3):165-8. doi: 10.1038/nrc2072. Epub 2007 Feb 1.
8
Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect.恶性转化过程中心肌素和p16的失活导致分化缺陷。
Cancer Cell. 2007 Feb;11(2):133-46. doi: 10.1016/j.ccr.2006.11.022.
9
Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway.肌肉恶病质由一条p53-PW1/Peg3依赖性途径调控。
Genes Dev. 2006 Dec 15;20(24):3440-52. doi: 10.1101/gad.412606.
10
Adipocyte differentiation from the inside out.脂肪细胞由内而外的分化。
Nat Rev Mol Cell Biol. 2006 Dec;7(12):885-96. doi: 10.1038/nrm2066.